No Data
No Data
Express News | Novavax Inc : Jefferies Cuts Target Price to $31 From $38
Jefferies Maintains Novavax(NVAX.US) With Buy Rating, Cuts Target Price to $31
Jefferies analyst Roger Song maintains $Novavax(NVAX.US)$ with a buy rating, and adjusts the target price from $41 to $31.According to TipRanks data, the analyst has a success rate of 29.5% and a
Novavax's Promising Outlook: Strong Market Positioning and Strategic Partnerships Fuel Buy Rating
COVID Activity Is Elevated Across 26 States In Summer Surge, Biden Remains In Isolation: 3 Vaccine Stocks To Watch
More than half of the states in the U.S. are experiencing significant Covid-19 activity in wastewater, and President Joe Biden remains in isolation after announcing Wednesday he caught the virus for
Here's How Much $100 Invested In Novavax 5 Years Ago Would Be Worth Today
Novavax (NASDAQ:NVAX) has outperformed the market over the past 5 years by 15.42% on an annualized basis producing an average annual return of 28.56%. Currently, Novavax has a market capitalization
Individual Investors Who Hold 46% of Novavax, Inc. (NASDAQ:NVAX) Gained 33%, Institutions Profited as Well
Key Insights Novavax's significant individual investors ownership suggests that the key decisions are influenced by shareholders from the larger public A total of 25 investors have a majority
No Data